Evaluation of a New Treatment for Migraine Attacks
Not Applicable
Completed
- Conditions
- Migraine
- Registration Number
- NCT01880671
- Lead Sponsor
- Karolinska University Hospital
- Brief Summary
The purpose of this study is to evaluate the efficacy of a novel therapy for treatment of migraine, pain reduction and relief of associated symptoms during ongoing migraine attacks, and presence of a preventive effect post treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
- Female or male subjects, in otherwise good health, 20 to 55 years of age
- Subjects who meet the ICHD-2 (2nd Edition of The International Headache Classification) criteria for migraine headache
- Subjects with a minimum of 1 migraine attack per month
- Attack duration of 4 to 72 hours
- Normal attack intensity of at least 4 on a 0-10 VAS-scale
Exclusion Criteria
- Completed heart surgery
- Cardiovascular disease
- Vascular damage on neck vessels
- Disease other than migraine of the CSN
- Severe disease of vital body organs
- Severe psychiatric disorders
- More than 6 migraine attacks per month
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change from baseline in pain intensity according to VAS-scales (0-10) Estimated 30 minutes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Karolinska University Hospital, Huddinge
🇸🇪Stockholm, Sweden
Karolinska University Hospital, Huddinge🇸🇪Stockholm, Sweden